Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI

Yoshiki Asayama, Akihiro Nishie, Kousei Ishigami, Yasuhiro Ushijima, Yukihisa Takayama, Nobuhiro Fujita, Yuichiro Kubo, Shinichi Aishima, Ken Shirabe, Takashi Yoshiura, Hiroshi Honda

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: We aimed to gain further insight in magnetic resonance imaging characteristics of mass-forming intrahepatic cholangiocarcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiated hepatocellular carcinoma (pHCC). Methods: Fourteen mICC and 22 pHCC nodules were included in this study. Two observers recorded the tumor shape, intratumoral hemorrhage, fat on chemical shift imaging, signal intensity at the center of the tumor on T2-weighted image, fibrous capsule, enhancement pattern on arterial phase of dynamic study, late enhancement three minutes after contrast injection (dynamic late phase), contrast uptake on hepatobiliary phase, apparent diffusion coefficient, vascular invasion, and intrahepatic metastasis. Results: Late enhancement was more common in mICC (n=10, 71%) than in pHCC (n=3, 14%) (P < 0.001). A fat component was observed in 11 pHCC cases (50%) versus none of mICC cases (P = 0.002). Fibrous capsule was observed in 13 pHCC cases (59%) versus none of mICC cases (P < 0.001). On T2-weighted images a hypointense area was seen at the center of the tumor in 43% of mICC (6/14) and 9% of pHCC (2/22) cases (P = 0.018). Other parameters were not significantly different between the two types of nodules. Conclusion: The absence of fat and fibrous capsule, and presence of enhancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC.

Original languageEnglish
Pages (from-to)96-104
Number of pages9
JournalDiagnostic and Interventional Radiology
Volume21
Issue number2
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Cholangiocarcinoma
Hepatocellular Carcinoma
Capsules
Fats
Magnetic Resonance Imaging
Neoplasms
gadolinium ethoxybenzyl DTPA
Contrast Media
Blood Vessels
Hemorrhage
Neoplasm Metastasis
Injections

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI. / Asayama, Yoshiki; Nishie, Akihiro; Ishigami, Kousei; Ushijima, Yasuhiro; Takayama, Yukihisa; Fujita, Nobuhiro; Kubo, Yuichiro; Aishima, Shinichi; Shirabe, Ken; Yoshiura, Takashi; Honda, Hiroshi.

In: Diagnostic and Interventional Radiology, Vol. 21, No. 2, 01.01.2015, p. 96-104.

Research output: Contribution to journalArticle

@article{e277fdb7ab2440c5afd658463e0cff9d,
title = "Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI",
abstract = "Purpose: We aimed to gain further insight in magnetic resonance imaging characteristics of mass-forming intrahepatic cholangiocarcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiated hepatocellular carcinoma (pHCC). Methods: Fourteen mICC and 22 pHCC nodules were included in this study. Two observers recorded the tumor shape, intratumoral hemorrhage, fat on chemical shift imaging, signal intensity at the center of the tumor on T2-weighted image, fibrous capsule, enhancement pattern on arterial phase of dynamic study, late enhancement three minutes after contrast injection (dynamic late phase), contrast uptake on hepatobiliary phase, apparent diffusion coefficient, vascular invasion, and intrahepatic metastasis. Results: Late enhancement was more common in mICC (n=10, 71{\%}) than in pHCC (n=3, 14{\%}) (P < 0.001). A fat component was observed in 11 pHCC cases (50{\%}) versus none of mICC cases (P = 0.002). Fibrous capsule was observed in 13 pHCC cases (59{\%}) versus none of mICC cases (P < 0.001). On T2-weighted images a hypointense area was seen at the center of the tumor in 43{\%} of mICC (6/14) and 9{\%} of pHCC (2/22) cases (P = 0.018). Other parameters were not significantly different between the two types of nodules. Conclusion: The absence of fat and fibrous capsule, and presence of enhancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC.",
author = "Yoshiki Asayama and Akihiro Nishie and Kousei Ishigami and Yasuhiro Ushijima and Yukihisa Takayama and Nobuhiro Fujita and Yuichiro Kubo and Shinichi Aishima and Ken Shirabe and Takashi Yoshiura and Hiroshi Honda",
year = "2015",
month = "1",
day = "1",
doi = "10.5152/dir.2014.13013",
language = "English",
volume = "21",
pages = "96--104",
journal = "Diagnostic and Interventional Radiology",
issn = "1305-3825",
publisher = "Turkish Society of Radiology",
number = "2",

}

TY - JOUR

T1 - Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI

AU - Asayama, Yoshiki

AU - Nishie, Akihiro

AU - Ishigami, Kousei

AU - Ushijima, Yasuhiro

AU - Takayama, Yukihisa

AU - Fujita, Nobuhiro

AU - Kubo, Yuichiro

AU - Aishima, Shinichi

AU - Shirabe, Ken

AU - Yoshiura, Takashi

AU - Honda, Hiroshi

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose: We aimed to gain further insight in magnetic resonance imaging characteristics of mass-forming intrahepatic cholangiocarcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiated hepatocellular carcinoma (pHCC). Methods: Fourteen mICC and 22 pHCC nodules were included in this study. Two observers recorded the tumor shape, intratumoral hemorrhage, fat on chemical shift imaging, signal intensity at the center of the tumor on T2-weighted image, fibrous capsule, enhancement pattern on arterial phase of dynamic study, late enhancement three minutes after contrast injection (dynamic late phase), contrast uptake on hepatobiliary phase, apparent diffusion coefficient, vascular invasion, and intrahepatic metastasis. Results: Late enhancement was more common in mICC (n=10, 71%) than in pHCC (n=3, 14%) (P < 0.001). A fat component was observed in 11 pHCC cases (50%) versus none of mICC cases (P = 0.002). Fibrous capsule was observed in 13 pHCC cases (59%) versus none of mICC cases (P < 0.001). On T2-weighted images a hypointense area was seen at the center of the tumor in 43% of mICC (6/14) and 9% of pHCC (2/22) cases (P = 0.018). Other parameters were not significantly different between the two types of nodules. Conclusion: The absence of fat and fibrous capsule, and presence of enhancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC.

AB - Purpose: We aimed to gain further insight in magnetic resonance imaging characteristics of mass-forming intrahepatic cholangiocarcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiated hepatocellular carcinoma (pHCC). Methods: Fourteen mICC and 22 pHCC nodules were included in this study. Two observers recorded the tumor shape, intratumoral hemorrhage, fat on chemical shift imaging, signal intensity at the center of the tumor on T2-weighted image, fibrous capsule, enhancement pattern on arterial phase of dynamic study, late enhancement three minutes after contrast injection (dynamic late phase), contrast uptake on hepatobiliary phase, apparent diffusion coefficient, vascular invasion, and intrahepatic metastasis. Results: Late enhancement was more common in mICC (n=10, 71%) than in pHCC (n=3, 14%) (P < 0.001). A fat component was observed in 11 pHCC cases (50%) versus none of mICC cases (P = 0.002). Fibrous capsule was observed in 13 pHCC cases (59%) versus none of mICC cases (P < 0.001). On T2-weighted images a hypointense area was seen at the center of the tumor in 43% of mICC (6/14) and 9% of pHCC (2/22) cases (P = 0.018). Other parameters were not significantly different between the two types of nodules. Conclusion: The absence of fat and fibrous capsule, and presence of enhancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC.

UR - http://www.scopus.com/inward/record.url?scp=84924664480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924664480&partnerID=8YFLogxK

U2 - 10.5152/dir.2014.13013

DO - 10.5152/dir.2014.13013

M3 - Article

C2 - 25698097

AN - SCOPUS:84924664480

VL - 21

SP - 96

EP - 104

JO - Diagnostic and Interventional Radiology

JF - Diagnostic and Interventional Radiology

SN - 1305-3825

IS - 2

ER -